Alnylam Pharmaceuticals
ALNY
#622
Rank
โ‚ฌ30.54 B
Marketcap
236,80ย โ‚ฌ
Share price
2.75%
Change (1 day)
43.88%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company